Budget impact analysis of transurethral water vapor therapy for treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia in the Spanish national healthcare system

References

• Cozar JM, Solsona E, Brenes F, et al. Manejo asistencial del paciente con hiperplasia benigna de próstata en España. Actas Urológicas Españolas. 2011;35(10):580–588.
   PubMedGoogle Scholar
• Berry SJ, Coffey DS, Walsh PC, et al. The development of human benign prostatic hyperplasia with age. J Urol. 1984;132(3):474–479.
   PubMed Web of Science ®Google Scholar
• Roehrborn CG. Benign prostatic hyperplasia: an overview. Rev Urol. 2005;7 Suppl 9(Suppl 9):S3–S14.
   PubMedGoogle Scholar
• Bushman W. Etiology, epidemiology, and natural history of benign prostatic hyperplasia. Urol Clin North Am. 2009;36:403–415.
   PubMed Web of Science ®Google Scholar
• O’Leary MP. Lower urinary tract symptoms/benign prostatic hyperplasia: maintaining symptom control and reducing complications. Urology. 2003;62:15–23.
   PubMed Web of Science ®Google Scholar
• Van Dijk MM, Wijkstra H, Debruyne FM, et al. The role of nocturia in the quality of life of men with lower urinary tract symptoms. BJU Int. 2010;105:1141–1146.
   PubMedGoogle Scholar
• Bruskewitz RC. Quality of life and sexual function in patients with benign prostatic hyperplasia. Rev Urol. 2003;5:72–80.
   PubMedGoogle Scholar
• Mitropoulos D, Anastasiou I, Giannopoulou C, et al. Symptomatic benign prostate hyperplasia: impact on partners’ quality of life. Eur Urol. 2002;41:240–244. discussion 244-245
   PubMed Web of Science ®Google Scholar
• Abrams P. New words for old: lower urinary tract symptoms for “prostatism.” BMJ. 1994;308:929–930.
   PubMed Web of Science ®Google Scholar
• Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37–49.
   Google Scholar
• Carrero-López VM, Cózar-Olmo JM, Miñana-López B. Benign prostatic hyperplasia and lower urinary tract symptoms. A review of current evidence. Actas Urol Esp. 2016;40:288–294.
   PubMed Web of Science ®Google Scholar
• Brenes Bermúdez FJ, Brotons Muntó F, Castiñeiras Fernández J, et al. [Consensus document on the management and follow-up of the male with lower urinary tract symptoms secondary to benign prostate hyperplasia]. Semergen. 2016;42:547–556.
   PubMedGoogle Scholar
• Juliao AA, Plata M, Kazzazi A, et al. American urological association and European Association of urology guidelines in the management of benign prostatic hypertrophy: revisited. Curr Opin Urol. 2012;22:34–39.
   PubMed Web of Science ®Google Scholar
• Rassweiler J, Schulze M, Stock C, et al. Bipolar transurethral resection of the prostate–technical modifications and early clinical experience. Minim Invasive Ther Allied Technol MITAT Off J Soc Minim Invasive Ther. 2007;16:11–21.
   PubMed Web of Science ®Google Scholar
• Ajib K, Mansour M, Zanaty M, et al. Photoselective vaporization of the prostate with the 180-W XPS-Greenlight laser: five-year experience of safety, efficiency, and functional outcomes. Can Urol Assoc J J Assoc Urol Can. 2018;12:E318–24.
   PubMed Web of Science ®Google Scholar
• Tan AHH, Gilling PJ. Holmium laser prostatectomy. BJU Int. 2003;92:527–530.
   PubMed Web of Science ®Google Scholar
• Green Z, Westwood J, Somani BK. What’s new in rezum: a transurethral water vapour therapy for BPH. Curr Urol Rep. 2019;20:39.
   PubMed Web of Science ®Google Scholar
• Lourenco T, Pickard R, Vale L, et al. Alternative approaches to endoscopic ablation for benign enlargement of the prostate: systematic review of randomised controlled trials. BMJ. 2008;337:a449.
   PubMedGoogle Scholar
• Mauskopf JA, Sullivan SD, Annemans L, et al. Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices—budget impact analysis. Value Health. 2007;10:336–347.
   Google Scholar
• Sullivan SD, Mauskopf JA, Augustovski F, et al. Budget impact analysis—principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014;17:5–14.
   Google Scholar
• Naimark DMJ, Kabboul NN, Krahn MD. The half-cycle correction revisited: redemption of a kludge. Med Decis Mak Int J Soc Med Decis Mak. 2013;33:961–970.
   PubMed Web of Science ®Google Scholar
• Lourenco T, Armstrong N, N’Dow J, et al. Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. Health Technol Assess Winch Engl. 2008;12(iii,ix–x, 1–146):169–515.
   Google Scholar
• National Institute for Health and Care Excellence (NICE). In: Overview | uroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia | guidance | NICE [Internet]. London: NICE. 2015. Available from: https://www.nice.org.uk/guidance/mtg26
   Google Scholar
• National Institute for Health and Care Excellence (NICE). Overview | rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia | guidance | NICE [Internet]. London: NICE; 2020 [cited 2021 Feb 4]. Available from: https://www.nice.org.uk/guidance/mtg49.
   Google Scholar
• Blissett RS, Blissett DB, Oselin M, et al. Transurethral water vapor therapy for treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: a cost-minimization and budget impact analysis from an Italian healthcare perspective. Minerva Urol Nephrol. 2022. in press.
   PubMedGoogle Scholar
• Garraway WM, Russell EB, Lee RJ, et al. Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract J R Coll Gen Pract. 1993;43:318–321.
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadística (INE). Población residente por fecha, sexo y edad [Internet]. Madrid: INE; 2021 [cited 2022 Mar 25]. Available from: https://www.ine.es/jaxiT3/Datos.htm?t=31304#!tabs-tabla.
   Google Scholar
• Verhamme KMC, Dieleman JP, Bleumink GS, et al. Treatment strategies, patterns of drug use and treatment discontinuation in men with LUTS suggestive of benign prostatic hyperplasia: the Triumph project. Eur Urol. 2003;44:539–545.
   PubMed Web of Science ®Google Scholar
• Roos NP, Wennberg JE, Malenka DJ, et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. N Engl J Med. 1989;320:1120–1124.
   PubMed Web of Science ®Google Scholar
• Madersbacher S, Lackner J, Brössner C, et al. Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol. 2005;47:499–504.
   PubMed Web of Science ®Google Scholar
• Thomas JA, Tubaro A, Barber N, et al. A multicenter randomized noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol. 2016;69:94–102.
   PubMed Web of Science ®Google Scholar
• Enikeev D, Taratkin M, Morozov A, et al. Long-term outcomes of holmium laser enucleation of the prostate: a 5-year single-center experience. J Endourol. 2020;34:1055–1063.
   PubMed Web of Science ®Google Scholar
• McVary K, Roehrborn CG. Lba01-06 five year results of the prospective, randomized controlled trial of water vapor thermal therapy for treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. J Urol. 2020; 203:e1021.
   Google Scholar
• Bachmann A, Tubaro A, Barber N, et al. 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial–the GOLIATH study. Eur Urol. 2014;65:931–942.
   PubMed Web of Science ®Google Scholar
• Peyronnet B, Robert G, Comat V, et al. Learning curves and perioperative outcomes after endoscopic enucleation of the prostate: a comparison between GreenLight 532-nm and holmium lasers. World J Urol. 2017;35:973–983.
   PubMed Web of Science ®Google Scholar
• Johnston MJ, Hindley R. Rezum water vapour therapy for benign prostatic hyperplasia. Trends in Urology and Men´s Disease. 2019:24–29.
   Google Scholar
• Ray A, Morgan H, Wilkes A, et al. The Urolift System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: a NICE Medical Technology Guidance. Appl Health Econ Health Policy. 2016;14:515–526.
   PubMed Web of Science ®Google Scholar
• Li T, Wilcox CS, Lipkowitz MS, et al. Rationale and strategies for preserving residual kidney function in dialysis patients. Am J Nephrol. 2019;50:411–421.
   PubMed Web of Science ®Google Scholar
• Mitjana Biosca S, Povo Martín I, Pallás Costa YS, et al. Rezum “Water Vapor Thermal Therapy” primeras experiencias en pacientes con crecimiento prostático benigno [Internet]. I Congreso Nacional Virtual de Urología: Asociación Española de Urología (AEU); 2020. [cited 9 Feb 2021]. Available from: https://aeu.es/reuniones/aeu2020/libroResumenes/verabstract.aspx?Sesion=0&Num=C-225.
   Google Scholar
• Abascal Junquera JM, Cecchini Rosell L, Salvador Lacambra C, et al. [Bipolar versus monopolar transurethral resection of the prostate: peroperative analysis of the results]. Actas Urol Esp. 2006;30:661–666.
   PubMedGoogle Scholar
• Placer J, Salvador C, Narváez MA, et al. Holmium laser enucleation of the prostate (HoLEP): evaluation of the first thousand patients. Eur Urol Suppl. 2019;18:e1907.
   Google Scholar
• Antoñanzas F, Brenes F, Molero JM, et al. [Cost-effectiveness of the combination therapy of dutasteride and tamsulosin in the treatment of benign prostatic hyperlasia in Spain]. Actas Urol Esp. 2011;35:65–71.
   PubMed Web of Science ®Google Scholar
• Ministerio de Sanidad. Consumo y Bienestar Social (MSCBS). Consulta Interactiva del SNS [Internet]. Madrid: MSCBS; 2021 [cited 2021 Feb 9]. Available from: https://pestadistico.inteligenciadegestion.mscbs.es/publicoSNS/C/rae-cmbd/rae-cmbd/grupos-relacionados-por-el-diagnostico-grd/grd-estadisticos-por-comunidad-autonoma-grupo-de-hospitales-servicios.
   Google Scholar
• Arlandis-Guzmán S, Brenes-Bermúdez F, Jiménez-Cidre MA, et al. [Cost effectiveness of Mirabegron and antimuscarinic drugs in patients with hiperactive bladder.]. Arch Esp Urol. 2018;71:809–824.
   PubMed Web of Science ®Google Scholar
• Montesino-Semper MF, Jimenez-Calvo JM, Cabases JM, et al. Cost-effectiveness analysis of the surgical treatment of female urinary incontinence using slings and meshes. Eur J Obstet Gynecol Reprod Biol. 2013;171:180–186.
   PubMed Web of Science ®Google Scholar
• Insausti I, Sáez de Ocáriz A, Galbete A, et al. Randomized comparison of prostatic artery embolization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia. J Vasc Interv Radiol JVIR. 2020;31:882–890.
   PubMed Web of Science ®Google Scholar
• Callejo Velasco D, López-Polín D´Olhaberriague A, Guerra Rodríguez M, et al. Evaluación económica de la vaporización fotoselectiva de la próstata para el tratamiento de la hiperplasia benigna de próstata. Madrid: Ministerio de Ciencia e Innovación; 2011.
   Google Scholar
• Roehrborn CG, Barkin J, Gange SN, et al. Five year results of the prospective randomized controlled prostatic urethral. L.I.F.T. Study. Can J Urol 2017;24:8802–8813.
   PubMed Web of Science ®Google Scholar
• McVary KT, Gange SN, Gittelman MC, et al. Minimally invasive prostate convective water vapor energy ablation: a multicenter, randomized, controlled study for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol. 2016;195:1529–1538.
   PubMed Web of Science ®Google Scholar
• Miner M, Rosenberg MT, Perelman MA. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function. Clin Ther. 2006;28:13–25.
   PubMed Web of Science ®Google Scholar
• Romero-Otero J, García-Gómez B, García-González L, et al. Critical analysis of a multicentric experience with holmium laser enucleation of the prostate for benign prostatic hyperplasia: outcomes and complications of 10 years of routine clinical practice. BJU Int. 2020;126:177–182.
   PubMed Web of Science ®Google Scholar
• Diario Oficial de la Generalitat de Catalunya (DOGC). ORDEN SLT-248-2016, de 29 de agosto, por la que se determinan para el año 2016 los precios unitarios para la contraprestación de la atención hospitalaria y especializada. [Internet]. Barcelona: DOGC; 2016 [cited 2021 Sep 10]. Available from: https://vlex.es/vid/orden-slt-248-2016-649669485.
   Google Scholar
• Diario Oficial de la Generalitat de Catalunya (DOGC). In: RESOLUCIÓ SLT/353/2013, de 13 de febrer, sobre la revisió de preus públics corresponents als serveis sanitaris que presta l’Institut Català de la Salut. [Internet]. Barcelona: DOGC. 2013. Available from: https://portaldogc.gencat.cat/utilsEADOP/PDF/6326/1287494.pdf
   Google Scholar
• Benejam-Gual JM, Sanz-Granda A, García-Miralles Grávalos R, et al. Análisis coste efectividad a 2 años del tratamiento quirúrgico de la hiperplasia benigna de próstata mediante vaporización fotoselectiva de la próstata con GreenLight–PhotoVaporization 120W versus resección transuretral de la próstata. Actas Urol Esp. 2014;38:238–243.
   PubMedGoogle Scholar
• Escobar LDP, García-Centeno MC. Impacto de la Covid-19 sobre las listas de espera quirúrgicas. Rev Esp Salud Pública. 2021;95:e1–12.
   Google Scholar
• Ulchaker JC, Martinson MS. Cost-effectiveness analysis of six therapies for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia. Clin Outcomes Res CEOR. 2018;10:29–43.
   PubMed Web of Science ®Google Scholar
• Chughtai B, Rojanasarot S, Neeser K, et al. Cost-effectiveness and budget impact of emerging minimally invasive surgical treatments for benign prostatic hyperplasia. J Health Econ Outcomes Res. 2021;8:42–50.
   PubMedGoogle Scholar
• Drummond M, O’Brien B, Stoddarts G, et al. Methods for economic evaluation of health care programmes. 2nd. Madrid: Ediciones Díaz Santos; 2001.
   Google Scholar